Suppr超能文献

CRISPR 伦理:对强大工具应用的道德考量。

CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.

机构信息

Department of Emergency Medicine, Yale School of Medicine, 464 Congress Avenue, New Haven, CT 06519-1362, USA.

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, 1340 Jefferson Park Avenue, Charlottesville, VA 22908, USA.

出版信息

J Mol Biol. 2019 Jan 4;431(1):88-101. doi: 10.1016/j.jmb.2018.05.044. Epub 2018 Jun 7.

Abstract

With the emergence of CRISPR technology, targeted editing of a wide variety of genomes is no longer an abstract hypothetical, but occurs regularly. As application areas of CRISPR are exceeding beyond research and biomedical therapies, new and existing ethical concerns abound throughout the global community about the appropriate scope of the systems' use. Here we review fundamental ethical issues including the following: 1) the extent to which CRISPR use should be permitted; 2) access to CRISPR applications; 3) whether a regulatory framework(s) for clinical research involving human subjects might accommodate all types of human genome editing, including editing of the germline; and 4) whether international regulations governing inappropriate CRISPR utilization should be crafted and publicized. We conclude that moral decision making should evolve as the science of genomic engineering advances and hold that it would be reasonable for national and supranational legislatures to consider evidence-based regulation of certain CRISPR applications for the betterment of human health and progress.

摘要

随着 CRISPR 技术的出现,对各种基因组进行靶向编辑不再是一个抽象的假设,而是经常发生的事情。随着 CRISPR 的应用领域超出了研究和生物医学治疗,全球范围内对该系统使用的适当范围存在着新的和现有的伦理问题。在这里,我们回顾了一些基本的伦理问题,包括:1)CRISPR 的使用应该在多大程度上被允许;2)CRISPR 应用的获取;3)是否有针对涉及人类受试者的临床研究的监管框架能够适应所有类型的人类基因组编辑,包括对生殖系的编辑;4)是否应该制定和公布规范不当 CRISPR 利用的国际法规。我们的结论是,随着基因组工程学的进步,道德决策应该发展,并且国家和超国家立法机构考虑对某些 CRISPR 应用进行基于证据的监管,以促进人类健康和进步,这是合理的。

相似文献

1
CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.
J Mol Biol. 2019 Jan 4;431(1):88-101. doi: 10.1016/j.jmb.2018.05.044. Epub 2018 Jun 7.
2
Thinking About CRISPR: The Ethics of Human Genome Editing.
CRISPR J. 2019 Oct;2(5):247-248. doi: 10.1089/crispr.2019.29072.rba.
3
Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective.
Plant Biotechnol J. 2020 Aug;18(8):1651-1669. doi: 10.1111/pbi.13383. Epub 2020 Apr 30.
5
Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Hum Reprod Update. 2016 Jun;22(4):411-9. doi: 10.1093/humupd/dmw005. Epub 2016 Feb 29.
6
Advances in therapeutic application of CRISPR-Cas9.
Brief Funct Genomics. 2020 May 20;19(3):164-174. doi: 10.1093/bfgp/elz031.
7
Ethical Issues Regarding CRISPR Mediated Genome Editing.
Curr Issues Mol Biol. 2018;26:103-110. doi: 10.21775/cimb.026.103. Epub 2017 Sep 7.
8
Application of CRISPR/Cas9 technology in sepsis research.
Brief Funct Genomics. 2020 May 20;19(3):229-234. doi: 10.1093/bfgp/elz040.
9
Development and application of CRISPR/Cas9 technologies in genomic editing.
Hum Mol Genet. 2018 Aug 1;27(R2):R79-R88. doi: 10.1093/hmg/ddy120.
10
Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
Plant Cell Physiol. 2018 Aug 1;59(8):1608-1620. doi: 10.1093/pcp/pcy079.

引用本文的文献

1
Reperfusion injury in STEMI: a double-edged sword.
Egypt Heart J. 2025 Sep 5;77(1):83. doi: 10.1186/s43044-025-00683-7.
4
Revolution of Biotechnology with CRISPR.
Exp Mol Med. 2025 Jul;57(7):1353-1354. doi: 10.1038/s12276-025-01452-x. Epub 2025 Jul 31.
5
Retinitis Pigmentosa: From Genetic Insights to Innovative Therapeutic Approaches-A Literature Review.
Medicina (Kaunas). 2025 Jun 29;61(7):1179. doi: 10.3390/medicina61071179.
6
Beyond human limits: the ethical, social, and regulatory implications of human enhancement.
Front Med (Lausanne). 2025 Jul 9;12:1595213. doi: 10.3389/fmed.2025.1595213. eCollection 2025.
7
Biosafety considerations triggered by genome-editing technologies.
Biosaf Health. 2025 May 13;7(3):141-151. doi: 10.1016/j.bsheal.2025.05.003. eCollection 2025 Jun.
8
The genetic technologies questionnaire in the Greek-speaking population: the moral judgement of the lay public.
Front Genet. 2025 May 13;16:1594724. doi: 10.3389/fgene.2025.1594724. eCollection 2025.
9
CRISPR/Cas-Based Prenatal Screening for Aneuploidy: Challenges and Opportunities for Early Diagnosis.
Medicina (Kaunas). 2025 Mar 27;61(4):610. doi: 10.3390/medicina61040610.
10
Exploring physiological and molecular dynamics of drought stress responses in plants: challenges and future directions.
Front Plant Sci. 2025 Mar 24;16:1565635. doi: 10.3389/fpls.2025.1565635. eCollection 2025.

本文引用的文献

1
A global observatory for gene editing.
Nature. 2018 Mar;555(7697):435-437. doi: 10.1038/d41586-018-03270-w.
2
Do CRISPR Germline Ethics Statements Cut It?
CRISPR J. 2018 Apr;1(2):115-125. doi: 10.1089/crispr.2017.0024.
3
ARRIGE Arrives: Toward the Responsible Use of Genome Editing.
CRISPR J. 2018 Apr;1(2):128-129. doi: 10.1089/crispr.2018.29012.mon.
4
The CRISPR tool kit for genome editing and beyond.
Nat Commun. 2018 May 15;9(1):1911. doi: 10.1038/s41467-018-04252-2.
5
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Nature. 2018 Apr 5;556(7699):57-63. doi: 10.1038/nature26155. Epub 2018 Feb 28.
6
Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Microbiology (Reading). 2018 Apr;164(4):464-474. doi: 10.1099/mic.0.000635. Epub 2018 Feb 28.
7
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
Science. 2018 Apr 27;360(6387):436-439. doi: 10.1126/science.aar6245. Epub 2018 Feb 15.
8
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.
Science. 2018 Apr 27;360(6387):439-444. doi: 10.1126/science.aaq0179. Epub 2018 Feb 15.
9
Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
Cell Physiol Biochem. 2018;45(2):656-666. doi: 10.1159/000487159. Epub 2018 Jan 31.
10
Editing the human genome: balancing safety and regulation.
Lancet. 2018 Feb 3;391(10119):402. doi: 10.1016/S0140-6736(18)30153-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验